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Abstract An increased hepatocellular hydration state (HS) that
can be induced by hypotonic stress or a high glutamine uptake
modulates the transcription of given genes in liver. This could be
important in the acute phase (AP) of a systemic inflammation
where both HS and glutamine uptake transiently increase in
liver. In HepG2 hepatoma cells cultured in conditions of
hypotonic stress or a high extracellular glutamine availability,
a specifically decreased expression of two human mRNAs,
namely those of K1-microglobulin/bikunin precursor (AMBP)
and K2-HS-glycoprotein, that are also down-regulated in liver by
AP, could be seen. A functional analysis of the AMBP promoter
indicated that this hypotonic stress-induced down-regulation
takes place at a transcriptional level. In these experiments, the
mRNA level and transcription of the glyceraldehyde-3-phosphate
dehydrogenase gene that are known to be unmodified in AP did
not exhibit any change. Given that hypotonic stress also up-
regulates the transcription of a liver gene that is also up-
regulated in AP [Meisse et al. (1998) FEBS Lett. 422, 346^348],
the AP-associated increase in hepatocellular HS now appears to
participate in the transcriptional control of both sets of genes
that are up- or down-regulated in AP.
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1. Introduction
In recent years, evidence has accumulated that an increased
hydration state (HS) can promote anabolic e¡ects on glucidic,
lipidic and protein metabolism in hepatocytes [1,2]. The hep-
atocellular HS is modulated by hormones, aniso-osmolarity,
amino acids and, notably, glutamine uptake. This HS pro-
vides a signal for control of the intracellular level of speci¢c
mRNAs [3]. For instance, an increased hepatocellular HS ex-
perimentally induced in vitro has been associated with an
increased level of the mRNA for a transcription factor such as
c-jun [3], cytoskeleton proteins such as L-actin and tubulin [3],
and the enzymes argininosuccinate synthetase [4] and orni-
thine decarboxylase [3] as well as with a decreased mRNA
level for the enzymes phosphoenolpyruvate carboxykinase
(PEPCK) and tyrosine aminotransferase [3]. However, quite
a limited number of studies, namely those for an intracellular
protein, i.e. L-actin, and an excreted protein, i.e. K2-Wacro-
globulin (K2-M), have as yet correlated such an up-regulated,
hepatic mRNA level with an increased transcription [5,6].
Whether the opposite situation, i.e. the down-regulation of
an mRNA level by the hepatocellular HS, also involves a
transcriptional step and which regulatory region(s) in the af-
fected gene is involved at this stage are currently unknown.
Most importantly, the relevance of such hepatocellular HS-
controlled, up- or down-regulation to given pathological sit-
uations largely remains to be explored.
The acute phase (AP) of a systemic in£ammation is a
unique condition to clarify the above issues, for three major
reasons. Firstly, the HS of liver cells is known to be increased
in vivo by an endotoxin-induced AP in rat. In such endotoxin-
challenged animals the hepatocytes exhibit increases in intra-
cellular water content and volume [7]. Secondly, a 8^10-fold
increase in hepatic uptake of blood-borne glutamine has been
reported in patients with sepsis [8] and in endotoxin-treated
rats [8^11]. It is likely that this increased uptake accounts, at
least partly, for the increased hepatocellular HS observed in
vivo in AP. Thirdly, the hepatic response to AP includes tran-
sient changes in the production of so-called acute-phase pro-
teins (APP) that are comprised of up- and down-regulated
plasma proteins designated positive and negative APPs, re-
spectively [12,13]. Although the transcriptional control of
APP genes by pro-in£ammatory cytokines such as tumor ne-
crosis factor (TNF), interleukin-1 (IL-1) and IL-6 is largely
proven [12^14], the question now arises as to whether the
hepatocellular HS also participates in this control. Indeed,
some of us have recently shown that a hypotonic stress-in-
duced increase in this hepatocellular HS is su⁄cient to up-
regulate the mRNA level for a positive APP, namely rat K2-
M, via a transcriptional step [6]. We now report for the ¢rst
time that hypotonic stress, e.g. induced by a hypotonic or a
glutamine-enriched culture medium, is su⁄cient to speci¢cally
down-regulate the mRNA level and transcription of negative
APP genes, namely the K1-microglobulin/bikunin precursor
(AMBP) and the K2-HS-glycoprotein (AHSG) genes. There-
fore, the hepatocellular HS is now added to the set of in£am-
mation-driven regulatory pathways that are able to up- or
down-regulate the hepatic transcription of positive or negative
APP genes, respectively.
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2. Materials and methods
2.1. Cell cultures
The human HepG2 hepatoma cell line was plated and maintained
at 37‡C in RPMI 1640 (Sigma) medium containing 2 mM L-gluta-
mine, 50 U/ml penicillin, 50 Wg/ml streptomycin and 10% fetal calf
serum (FCS). However, in all media listed below FCS was reduced to
2%. Tonicity experiments were carried out with an isotonic medium
(iso) (NaCl 145 mM; 300 mosmol/kg of H2O) or a hypotonic medium
(hypo) (NaCl 95 mM; 200 mosmol/kg of H2O) made by adjusting the
NaCl concentration of the RPMI medium. A further, ra⁄nose-sup-
plemented, isotonic medium (isora¡) was made by supplementing the
hypo medium with 100 mM ra⁄nose. Cell cultures with di¡erent
amounts of glutamine were carried out in RPMI 1640 medium sup-
plemented (glutamine-enriched medium) or not (control medium) with
10 mM L-glutamine. Cell viability, as evaluated by measuring the
intracellular ATP content, was unchanged at the end of incubation
periods in the cells incubated in either medium (data not shown).
2.2. RNA isolation and Northern blot quantitation with cDNA probes
Total RNAs were extracted by an acidic guanidinium thiocyanate/
phenol/chloroform procedure, electrophoresed (20 Wg per lane), blot-
ted and hybridized with [K32P]dCTP-labeled cDNA as in [15]. Full-
length cDNA probes included those for the human AMBP [15], the
human AHSG (courtesy of Prof. P. Arnaud, Charleston, SC, USA),
the human GAPDH (a kind gift from Dr. J.P. Borel, Reims, France)
and the rat 18S (kindly provided by Dr. R. Vrancks, Paris, France).
The autoradiographic signals obtained with a given cDNA probe were
quantitated by densitometric scanning with an image analyzer (Bio-
com 500; Biocom, Les Ulis, France). In all experiments we veri¢ed
that the signal-to-amount ratio was linear in the range of mRNA
amounts studied with each probe (not detailed). All densitometric
values for a given mRNA were normalized with the 18S signals ob-
tained on the same blot.
2.3. Reporter plasmids, HepG2 cell transfections and Cat/L-gal assays
p47 is a pCMV-L-galactosidase (L-gal) plasmid with the bacterial L-
gal gene under the control of the cytomegalovirus immediate-early
enhancer/promoter region. pBLcat5 with the chloramphenicol acetyl-
transferase (cat) gene under the control of Herpes simplex thymidine
kinase (tk) promoter (3109/+51) and the promoter-free pBLcat6 plas-
mid have been described elsewhere [16]. pGAPDH/cat with the human
GAPDH promoter (3488/+21) fused to cat in pUC/cat and the pro-
moter-free pUC/cat plasmid [17] were a courtesy from Dr. M.
Alexander (Harvard). pSV2/cat with the early enhancer/promoter of
the simian virus 40 fused to cat, p-4964AMBP/cat and p-2929AMBP/
cat with the human AMBP enhancer/promoter (from 34964 to +57
and from 32929 to +57, respectively) fused to cat in pUMSV0cat and
the promoter-free pUMSV0cat plasmid have been detailed previously
[18]. The HepG2 cells were plated in 6 cm plastic Petri dishes and ¢rst
cultured in the standard plating medium described above. When the
cells reached 70% con£uence, the standard medium was replaced with
minimum essential medium and 8 Wg of Cat plasmid and 1 Wg p47
were co-transfected by a Ca3(PO4)2 precipitation method [18]. After
12 h exposure to the precipitate, the cells were shifted to the iso, hypo
or isora¡ medium as listed above, further cultured for 24 h and ¢nally
harvested by scraping. A cell extract was assayed for L-gal activity
and for Cat activity and the ¢nal values of Cat activities are expressed
as cpm [3H]acetyl-chloramphenicol/L-gal unit as previously detailed
[19]. The low activity provided by each control, promoterless plasmid
was subtracted from that obtained with the paired promoter/cat con-
struct(s). In every experiment the transfection of each plasmid was
done in triplicate.
2.4. Statistics
Statistical signi¢cance of di¡erences was analyzed using the Mann-
Whitney non-parametric test.
3. Results
We ¢rst evaluated whether a hypotonic stress down-regu-
lates in a gene-speci¢c fashion the level of endogenous
mRNAs in the human HepG2 hepatoma cells. The hepatic
mRNAs under study comprised the GAPDH mRNA that is
not regulated by AP [20,21] and the AMBP and AHSG
mRNAs that both encode well-known negative APPs
[13,15]. As judged from Northern blots (Fig. 1), the abun-
dance of the endogenous GAPDH mRNA was not modi¢ed
by a cell culture carried out for 24 h in a low-NaCl, hypo
medium (as de¢ned in Section 2) as compared to the control,
iso medium. In contrast, the AMBP and AHSG mRNA levels
were signi¢cantly decreased by this incubation in the hypo
medium. In order to discriminate between a possible NaCl-
speci¢c e¡ect and a genuine, hypotonicity-driven one, an iso-
ra¡ medium that was simultaneously isotonic and low in
NaCl was also tested. In the isora¡ medium the abundance
of AMBP and AHSG mRNAs returned to control values
while the GAPDH mRNA level remained unchanged (Fig.
1). Therefore hypotonic stress per se down-regulates the ex-
pression of mRNAs that encode negative APPs, namely
AMBP and AHSG, while it does not a¡ect the expression
of an mRNA whose level is known to be AP-independent,
namely GAPDH.
Given that glutamine uptake by liver cells increases during
AP [8^11] we evaluated whether glutamine speci¢cally down-
regulates the level of mRNAs for negative APPs. Glutamine is
known to be transported across liver cell membranes by a Na-
dependent transporter whose activity in HepG2 cells over-
comes that in hepatocytes [22,23]. Therefore our experiments
were carried out in HepG2 cells incubated in the presence of
large amounts of extracellular glutamine. When these cells
were cultured in a glutamine-enriched medium (see Section
2) for 24 h the abundance of both AMBP and AHSG mRNAs
was signi¢cantly decreased whereas that of GAPDH mRNA
remained unchanged (Fig. 2). The e¡ect of a glutamine addi-
tion upon AMBP and AHSG mRNA levels was a relatively
slow and persistent event as it was not observed after a 12 h
incubation period but it was still visible at 48 h (data not
shown). These results indicate that glutamine down-regulates
the level of two negative APP mRNAs, i.e. AMBP and
AHSG, whereas it does not a¡ect the GAPDH mRNA level
in HepG2 cells. Overall, both hypotonic stress and extracel-
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Fig. 1. In£uence of hypotonic stress upon AMBP, AHSG and
GAPDH mRNA levels in HepG2 cells. The HepG2 cells were main-
tained for 24 h in an isotonic (iso; black bars), low-NaCl, hypoton-
ic (hypo; open bars) or low-NaCl, ra⁄nose-supplemented, isotonic
medium (isora¡; hatched bars). Total cellular RNAs were subjected
to Northern blot analysis and successively probed with human
AMBP, AHSG, GAPDH and 18S cDNAs. For each mRNA popu-
lation, the autoradiographic signals were normalized with the 18S
signals on the same blot. Values (mean þ S.E.M.) for n independent
experiments (nv 3) are expressed as percent of the control value
(iso). *Signi¢cant di¡erence (P6 0.05) between hypo and iso and
hypo and isora¡.
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lular glutamine enrichment promote an identical end result,
i.e. a speci¢c down-regulation of the mRNA level for negative
APPs in HepG2 cells.
We next tested whether the e¡ect of hypotonic stress as
observed above on AMBP mRNA takes place at the tran-
scriptional level and in a gene-speci¢c fashion. Given that
the endogenous expression of AMBP is low in HepG2 cells,
nuclear run-on experiments turned out to be poorly informa-
tive (data not shown). Therefore, we performed experiments
where the promoter of AMBP or control gene was fused to
the bacterial cat reporter gene. The transcriptional activities of
these promoter/cat constructs transiently transfected (along
with a L-gal plasmid for normalization) in HepG2 cells that
underwent or not a hypotonic stress are shown in Fig. 3.
First, the transcriptional activity of the GAPDH promoter
was not a¡ected by a hypo medium nor was it modi¢ed by
an isora¡ medium. Likewise, the transcriptions driven by pro-
moters of viral origin, namely the SV40 early enhancer/pro-
moter and the HSV tk promoter, were not a¡ected by either
culture condition. In contrast, the transcriptional activity of
the AMBP gene encoding a negative APP was signi¢cantly
decreased in HepG2 cells incubated in the hypo medium
and returned to control values when the cells were cultured
in an isora¡ medium. This result was observed with two
AMBP/cat constructs covering the AMBP gene from 34964
to +57 or from 32929 to +57. Similar results were obtained in
experiments where HepG2 cells were transfected by electro-
poration instead of Ca3(PO4)2 precipitation (data not shown).
Elsewhere, we ruled out that the speci¢c activities of the Cat
or L-gal enzymes might be in£uenced by the ionic content in
cells incubated in hypo medium. Indeed, the activities of pu-
ri¢ed Cat and L-gal enzymes remained unchanged when tested
in the presence of variable amounts of cell extracts from
mock-transfected HepG2 cells incubated in hypo or iso media
(data not shown). Therefore, our results demonstrate that
hypotonic stress per se is su⁄cient to decrease the transcrip-
tional activity of a human gene (AMBP) encoding a negative
APP in liver cells and that this e¡ect is mediated by the 5P
control region of this tonicity-responsive gene.
4. Discussion
Although the pro-in£ammatory cytokines TNF-K, IL-1 and
IL-6 and related intracellular signalling pathways and nuclear
factors that trigger the transcription of APP genes in liver
have been largely deciphered (reviewed in [12,14]) it cannot
be excluded that other AP mediators contribute to the
changes in APP levels observed in vivo. Since in AP both
an increased hepatocellular HS and an increased glutamine
uptake in liver take place [7,8], we investigated whether either
event participates in a speci¢c regulation of APP mRNA lev-
els in vitro. We have now demonstrated that hypotonic stress
and an increase in extracellular glutamine availability are both
able to speci¢cally decrease the level of hepatic mRNAs that
encode well-known negative APPs, i.e. AMBP and AHSG,
without modifying that of another mRNA whose product is
not an APP, namely GAPDH. The observed similarity in the
¢nal e¡ects produced by hypotonic stress and glutamine was
not unexpected. Indeed, up-regulated glutamine uptake in
hepatocyte has been shown to increase the hepatocellular
HS, an event that in turn results in cell swelling [24,25]. There-
fore, our study now suggests that during AP glutamine par-
ticipates in the regulation of AMBP and AHSG mRNA levels
in the liver via an increase in hepatocellular HS and cell swell-
ing. Accordingly, we have selected hypotonic stress to further
study the transcription of a negative APP gene under condi-
tions of increased hepatocellular HS.
Our data demonstrate that the down-regulation of the
AMBP mRNA level promoted by hypotonic stress is medi-
ated, at least partly, by the 5P £anking region of the cognate
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Fig. 3. In£uence of hypotonic stress upon various promoter/cat con-
structs transiently transfected in HepG2 cells. The transcriptional
activities of two control promoters of viral origin (SV40, simian vi-
rus 40 early promoter/enhancer; tk, Herpes simplex thymidine kin-
ase promoter), a control promoter of human origin (GAPDH) and
two promoters for human, a negative APP gene (AMBP) are
shown. The extent of the 5P £anking region for the AMBP pro-
moter in various constructs is summarized as follows: AMBP
(34964) and AMBP (32929) cover the AMBP promoter from
34964 to +57 and 32929 to +57, respectively. The constructs were
tested in HepG2 cells cultured for 24 h in an isotonic (iso; black
bars), low-NaCl, hypotonic (hypo; open bars) or low-NaCl, ra⁄n-
ose-supplemented, isotonic medium (isora¡; hatched bars). For each
promoter, the values (mean þ S.E.M.) for n independent experiments
(nv 3) are expressed as percent of the control value (iso). *Signi¢-
cant di¡erence (P6 0.05) between hypo and iso and hypo and iso-
ra¡.
Fig. 2. In£uence of a glutamine-enriched culture medium upon
AMBP, AHSG and GAPDH mRNA levels in HepG2 cells. The
HepG2 cells were maintained for 24 h in the absence (control me-
dium; black bars) or in the presence (glutamine-enriched medium;
open bars) of 10 mM glutamine. Values (mean þ S.E.M.) for n inde-
pendent experiments (nv 4) are expressed as percent of the control
value (control medium). *Signi¢cant di¡erence (P6 0.05).
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gene even though a role for hypotonic stress on AMBP
mRNA stability cannot be excluded. A tonicity-responsive
element (TonE: TGGAAAATC) has been previously charac-
terized in two genes, namely the aldose reductase (AR) [26,27]
and betaine transporter (BT) [28,29] genes that are both up-
regulated by hypertonic stress in renal medulla. The AR gene
is also up-regulated by hypertonic stress in liver and a short
enhancer (AEE; core: GAAGAGTG) has been identi¢ed in
the rat gene where this element controls the hypertonicity-
driven transcription in a fashion that does not depend on
the neighboring TonE [30].
Whether these hypertonicity-responsive elements are also
able to participate in a response to hypotonic stress had not
been studied. A search in the AMBP 5P £anking region has
now revealed that a perfect TonE sequence is present at posi-
tion 33744. However, this sequence alone is unlikely to ac-
count for our present results as an AMBP/cat construct lack-
ing this TonE sequence (p-2929AMBP/cat) fully retains the
negative response to hypotonic stress. Elsewhere, another el-
ement (oligo B: TGAGACNNNGTCTCA, which is palin-
dromic in nature and harbors a A/T-rich cluster ahead of it)
mediates in various cell lines the hypertonicity-driven up-reg-
ulation of several genes [31]. Thus, the set of hypertonicity-
responsive elements TonE and oligo B that are up-regulated
by hypertonic stress appear not to be involved or, at least, to
be dispensable in the response of the AMBP gene to hypo-
tonic stress in liver. Therefore, the 5P £anking sequence of the
AMBP gene now provides a new tool to identify the sequen-
ce(s) and transcription factor(s) involved in the hepatic re-
sponse to hypotonic stress.
This is the ¢rst report that hypotonic stress per se is su⁄-
cient to down-regulate the transcription of a negative APP-
encoding gene. Strikingly, this down-regulation is opposed to
the hypotonicity-driven, transcriptional up-regulation of a
gene encoding a well-known positive APP, as recently shown
with the rat a2-M gene [6], or that of another gene, namely the
rat L-actin gene [5] whose up-regulation in endotoxin-chal-
lenged hepatocytes has been observed [32]. Also of great inter-
est is the fact that c-jun is another gene whose hepatic mRNA
level is up-regulated by hypotonicity and AP [3,33]. All togeth-
er, these past results and our present ¢ndings indicate that the
transient (and possibly glutamine-driven) hypotonic stress of
liver cells that takes place in AP [7] simultaneously participates
in the up- and down-regulated synthesis of both sets of positive
and negative APPs, respectively, in liver.
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